1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global CAR-T Cell Therapy Market
2.3. Global CAR-T Cell Therapy Market, By Type of Targeted Antigens, 2025 (US$ Million)
2.4. Global CAR-T Cell Therapy Market, By Type of Approach, 2025 (US$ Million)
2.5. Global CAR-T Cell Therapy Market, By Therapeutic Areas, 2025 (US$ Million)
2.6. Global CAR-T Cell Therapy Market, By Product, 2025 (US$ Million)
2.7. Global CAR-T Cell Therapy Market, By End Users, 2025 (US$ Million)
2.8. Global CAR-T Cell Therapy Market, By Geography, 2025 (US$ Million)
2.9. Attractive Investment Proposition by Geography, 2025

3. CAR-T Cell Therapy Market: Competitive Analysis
3.1. Market Positioning of Key CAR-T Cell Therapy Market Vendors
3.2. Strategies Adopted by CAR-T Cell Therapy Market Vendors

4. CAR-T Cell Therapy Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global CAR-T Cell Therapy Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape

5. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. CD19
5.3.2. CD20
5.3.3. CD22
5.3.4. CD30
5.3.5. CD33
5.3.6. BCMA
5.3.7. MSLN
5.3.8. Others

6. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. Autologous
6.3.2. Allogeneic

7. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2025 Versus 2034
7.3. Market Segmentation
7.3.1. Acute lymphoblastic leukemia (ALL),
7.3.2. Diffuse large B-Cell lymphoma (DLBCL),
7.3.3. Multiple Myeloma (MM),
7.3.4. Acute Myeloid Leukemia (AML)
7.3.5. Others

8. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2025 Versus 2034
8.3. Market Segmentation
8.3.1. Axicabtagene Ciloleucel,
8.3.2. Tisagenlecleucel,
8.3.3. Lisocabtagene Maraleucel,
8.3.4. Bb2121

9. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Growth & Revenue Analysis: 2025 Versus 2034
9.3. Market Segmentation
9.3.1. Hospitals
9.3.2. Cancer Treatment Centers
9.3.3. Others

10. North America CAR-T Cell Therapy Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
10.3. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
10.4. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
10.5. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
10.6. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
10.7. CAR-T Cell Therapy Market: By Region, 2024-2034, USD (Million)
10.7.1.North America
10.7.1.1. U.S.
10.7.1.1.1. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
10.7.1.1.2. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
10.7.1.1.3. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
10.7.1.1.4. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
10.7.1.1.5. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
10.7.1.2. Canada
10.7.1.2.1. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
10.7.1.2.2. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
10.7.1.2.3. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
10.7.1.2.4. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
10.7.1.2.5. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
10.7.1.3. Rest of North America
10.7.1.3.1. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
10.7.1.3.2. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
10.7.1.3.3. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
10.7.1.3.4. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
10.7.1.3.5. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)

11. UK and European Union CAR-T Cell Therapy Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
11.3. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
11.4. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
11.5. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
11.6. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
11.7. CAR-T Cell Therapy Market: By Region, 2024-2034, USD (Million)
11.7.1.UK and European Union
11.7.1.1. UK
11.7.1.1.1. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
11.7.1.1.2. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
11.7.1.1.3. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
11.7.1.1.4. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
11.7.1.1.5. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
11.7.1.2. Germany
11.7.1.2.1. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
11.7.1.2.2. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
11.7.1.2.3. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
11.7.1.2.4. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
11.7.1.2.5. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
11.7.1.3. Spain
11.7.1.3.1. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
11.7.1.3.2. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
11.7.1.3.3. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
11.7.1.3.4. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
11.7.1.3.5. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
11.7.1.4. Italy
11.7.1.4.1. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
11.7.1.4.2. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
11.7.1.4.3. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
11.7.1.4.4. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
11.7.1.4.5. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
11.7.1.5. France
11.7.1.5.1. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
11.7.1.5.2. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
11.7.1.5.3. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
11.7.1.5.4. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
11.7.1.5.5. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
11.7.1.6. Rest of Europe
11.7.1.6.1. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
11.7.1.6.2. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
11.7.1.6.3. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
11.7.1.6.4. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
11.7.1.6.5. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)

12. Asia Pacific CAR-T Cell Therapy Market, 2024-2034, USD (Million)
12.1. Market Overview
12.2. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
12.3. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
12.4. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
12.5. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
12.6. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
12.7. CAR-T Cell Therapy Market: By Region, 2024-2034, USD (Million)
12.7.1.Asia Pacific
12.7.1.1. China
12.7.1.1.1. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
12.7.1.1.2. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
12.7.1.1.3. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
12.7.1.1.4. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
12.7.1.1.5. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
12.7.1.2. Japan
12.7.1.2.1. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
12.7.1.2.2. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
12.7.1.2.3. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
12.7.1.2.4. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
12.7.1.2.5. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
12.7.1.3. India
12.7.1.3.1. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
12.7.1.3.2. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
12.7.1.3.3. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
12.7.1.3.4. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
12.7.1.3.5. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
12.7.1.4. Australia
12.7.1.4.1. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
12.7.1.4.2. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
12.7.1.4.3. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
12.7.1.4.4. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
12.7.1.4.5. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
12.7.1.5. South Korea
12.7.1.5.1. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
12.7.1.5.2. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
12.7.1.5.3. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
12.7.1.5.4. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
12.7.1.5.5. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
12.7.1.6. Rest of Asia Pacific
12.7.1.6.1. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
12.7.1.6.2. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
12.7.1.6.3. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
12.7.1.6.4. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
12.7.1.6.5. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)

13. Latin America CAR-T Cell Therapy Market, 2024-2034, USD (Million)
13.1. Market Overview
13.2. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
13.3. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
13.4. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
13.5. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
13.6. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
13.7. CAR-T Cell Therapy Market: By Region, 2024-2034, USD (Million)
13.7.1.Latin America
13.7.1.1. Brazil
13.7.1.1.1. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
13.7.1.1.2. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
13.7.1.1.3. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
13.7.1.1.4. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
13.7.1.1.5. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
13.7.1.2. Mexico
13.7.1.2.1. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
13.7.1.2.2. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
13.7.1.2.3. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
13.7.1.2.4. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
13.7.1.2.5. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
13.7.1.3. Rest of Latin America
13.7.1.3.1. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
13.7.1.3.2. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
13.7.1.3.3. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
13.7.1.3.4. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
13.7.1.3.5. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)

14. Middle East and Africa CAR-T Cell Therapy Market, 2024-2034, USD (Million)
14.1. Market Overview
14.2. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
14.3. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
14.4. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
14.5. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
14.6. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
14.7. CAR-T Cell Therapy Market: By Region, 2024-2034, USD (Million)
14.7.1.Middle East and Africa
14.7.1.1. GCC
14.7.1.1.1. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
14.7.1.1.2. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
14.7.1.1.3. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
14.7.1.1.4. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
14.7.1.1.5. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
14.7.1.2. Africa
14.7.1.2.1. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
14.7.1.2.2. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
14.7.1.2.3. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
14.7.1.2.4. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
14.7.1.2.5. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)
14.7.1.3. Rest of Middle East and Africa
14.7.1.3.1. CAR-T Cell Therapy Market: By Type of Targeted Antigens, 2024-2034, USD (Million)
14.7.1.3.2. CAR-T Cell Therapy Market: By Type of Approach, 2024-2034, USD (Million)
14.7.1.3.3. CAR-T Cell Therapy Market: By Therapeutic Areas, 2024-2034, USD (Million)
14.7.1.3.4. CAR-T Cell Therapy Market: By Product, 2024-2034, USD (Million)
14.7.1.3.5. CAR-T Cell Therapy Market: By End Users, 2024-2034, USD (Million)

15. Company Profile
15.1. Gilead Sciences (Kite Pharma) (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
15.2. Novartis
15.3. Pfizer
15.4. Allogene Therapeutics
15.5. Bluebird Bio
15.6. Mustang Bio
15.7. Celgene Corporation (Juno Therapeutics)
15.8. Celyad
15.9. Sorrento Therapeutics
15.10. Fate Therapeutics